New test predicts which BRCA2 gene mutations lead to breast, ovarian cancers
 

A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.

More...